Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Lambadiari, Vaia ^a   Kadoglou, Nikolaos P E ^a   Stasinos, Vassilios ^a   Maratou, Eirini ^b   Antoniadis, Aias ^a   Kolokathis, Fotios ^a   Parissis, John ^a   Hatziagelaki, Erifili ^a   Iliodromitis, Efstathios K ^a   Dimitriadis, George ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Prevention and Treatment of Diabetes Mellitus and Its Complications   (Greece)

Author keywords

Adipokines; Coronary artery disease; Myocardial infarction; Retinol Binding Protein 4

Indexed keywords

RETINOL BINDING PROTEIN 4; BIOLOGICAL MARKER; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; GENSINI SCORE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; BLOOD; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; METABOLISM; SEVERITY OF ILLNESS INDEX;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETINOL-BINDING PROTEINS, PLASMA; SEVERITY OF ILLNESS INDEX;

EID: 84906846586     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-014-0121-z     Document Type: Article

References (38)

1. van Holten TC, Waanders LF, de Groot PG, Vissers J, Hoefer IE, Pasterkamp G, Prins MW, Roest M. Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses. PLoS One 2013, 22:e62080. 10.1371/journal.pone.0062080.
2. Hemingway H, Philipson P, Chen R, Fitzpatrick NK, Damant J, Shipley M, Abrams KR, Moreno S, McAllister KS, Palmer S, Kaski JC, Timmis AD, Hingorani AD. Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med 2010, 7:e1000286. 10.1371/journal.pmed.1000286, 20532236.
3. Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC, Wilson PW. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009, 119:2408-2416. 10.1161/CIRCULATIONAHA.109.192278, 19364974.
4. Kadoglou NP, Lampropoulos S, Kapelouzou A, Gkontopoulos A, Theofilogiannakos EK, Fotiadis G, Kottas G. Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease-KOZANI STUDY. Transl Res 2010, 155:238-246. 10.1016/j.trsl.2010.01.004, 20403579.
5. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436:356-362. 10.1038/nature03711, 16034410.
6. Broch M, Vendrell J, Ricart W, Richart C, Ferna´ndez-Real JM. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care 2007, 30:1802-1806. 10.2337/dc06-2034, 17416795.
7. Promintzer M, Krebs M, Todoric J, Luger A, Bischof MG, Nowotny P, Wagner O, Esterbauer H, Anderwald C. Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab 2007, 92:4306-4312. 10.1210/jc.2006-2522, 17726077.
8. Graham TE, Yang Q, Blu¨her M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006, 15:2552-2563. 10.1056/NEJMoa054862.
9. Lee JW, Im JA, Lee HR, Shim JY, Youn BS, Lee DC. Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women. Obesity (Silver Spring) 2007, 15:2225-2232. 10.1038/oby.2007.264.
10. Friebe D, Neef M, Erbs S, Dittrich K, Kratzsch J, Kovacs P, Blu¨her M, Kiess W, Ko¨rner A. Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children. Int J Pediatr Obes 2011, 6:345-352. 10.3109/17477166.2010.491228.
11. Conroy R, Espinal Y, Fennoy I, Accacha S, Boucher-Berry C, Carey DE, Close S, DeSantis D, Gupta R, Hassoun AA, Iazzetti L, Jacques FJ, Jean AM, Michel L, Pavlovich K, Rapaports R, Rosenfeld W, Shamoon E, Shelov S, Speiser PW, Ten S, Rosenbaum M. Retinol binding protein 4 is associated with adiposity-related co-morbidity risk factors in children. J Pediatr Endocrinol Metab 2011, 24:913-919. 10.1515/JPEM.2011.297, 22308842.
12. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 2007, 92:2712-2719. 10.1210/jc.2006-1249, 17440021.
13. Klo¨ting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Fasshauer M, Scho¨n MR, Stumvoll M, Blu¨her M, Kahn BB. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 2007, 6:79-87. 10.1016/j.cmet.2007.06.002, 17618858.
14. Christou GA, Tellis CC, Elisaf MS, Tselepis AD, Kiortsis DN. The changes in plasma retinol-binding protein 4 levels are associated with those of the apolipoprotein B-containing lipoproteins during dietary and drug treatment. Angiology 2012, 63:67-75. 10.1177/0003319711407628, 21602259.
15. Huang G, Wang D, Khan UI, Zeb I, Manson JE, Miller V, Hodis HN, Budoff MJ, Merriam GR, Harman SM, Brinton EA, Cedars MI, Lobo RA, Naftolin F, Santoro N, Taylor HS, Wildman RP, Su Y. Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: Cross-sectional analyses from the KEEPS Study. Cardiovasc Diabetol 2012, 11:52. 10.1186/1475-2840-11-52, 22587616.
16. Aust G, Uptaite-Patapoviene M, Scholz M, Richter O, Rohm S, Bluher M. Circulating Nampt and RBP4 levels in patients with carotid stenosis undergoing carotid endarterectomy (CEA). Clin Chim Acta 2011, 412:1195-1200. 10.1016/j.cca.2011.03.008, 21406189.
17. Mallat Z, Simon T, Benessiano J, Cle´ment K, Taleb S, Wareham NJ, Luben R, Khaw KT, Tedgui A, Boekholdt SM. Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. J Clin Endocrinol Metab 2009, 94:255-260. 10.1210/jc.2008-0253, 18854400.
18. Martinez-Hervas S, Real JT, Priego MA, Carratala´ A, Sniderman AD, Carmena R, Ascaso JF. Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population. Int J Clin Pract 2013, 67:81-88. 10.1111/j.1742-1241.2012.02998.x, 23241052.
19. Ingelsson E, Lind L. Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the elderly. Diabetes Care 2009, 32:733-735. 10.2337/dc08-1656, 19114616.
20. Xiao Y, Xu A, Hui X, Zhou P, Li X, Zhong H, Tang W, Huang G, Zhou Z. Circulating lipocalin-2 and retinol-binding protein 4 are associated with intima-media thickness and subclinical atherosclerosis in patients with type 2 diabetes. PLoS One 2013, 8:e66607. 10.1371/journal.pone.0066607, 23799122.
21. Bobbert T, Raila J, Schwarz F, Mai K, Henze A, Pfeiffer AF, Schweigert FJ, Spranger J. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis 2010, 213:549-551. 10.1016/j.atherosclerosis.2010.07.063, 20832065.
22. Ingelsson E, Sundstro¨m J, Melhus H, Michae¨lsson K, Berne C, Vasan RS, Rise´rus U, Blomhoff R, Lind L, Arnlo¨v J. Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 2009, 206:239-244. 10.1016/j.atherosclerosis.2009.02.029, 19339013.
23. Kim HJ, Yoo HS, Kim PK, Kim MR, Lee HW, Kim CW. Comparative analysis of serum proteomes of patients with cardiovascular disease. Clin Biochem 2011, 44:178-184. 10.1016/j.clinbiochem.2010.09.027, 20934420.
24. Sun Q, Kiernan UA, Shi L, Phillips DA, Kahn BB, Hu FB, Manson JE, Albert CM, Rexrode KM. Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses' health study. Circulation 2013, 127:1938-1947. 10.1161/CIRCULATIONAHA.113.002073, 23584360.
25. Calo` LA1, Maiolino G, Pagnin E, Vertolli U, Davis PA. Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodelling defences. Eur J Clin Invest 2014, 44:567-572. 10.1111/eci.12270, 24739026.
26. Takebayashi K1, Sohma R, Aso Y, Inukai T. Effects of retinol binding protein-4 on vascular endothelial cells. Biochem Biophys Res Commun 2011, 29(408):58-64. 10.1016/j.bbrc.2011.03.116.
27. Cubedo J1, Padro´ T, Cinca J, Mata P, Alonso R, Badimon L. Retinol-binding protein 4 levels and susceptibility to ischaemic events in men. Eur J Clin Invest 2014, 44:266-275. 10.1111/eci.12229, 24720534.
28. Kadoglou NP, Gkontopoulos A, Kapelouzou A, Fotiadis G, Theofilogiannakos EK, Kottas G, Lampropoulos S. Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. Clin Chim Acta 2011, 412:48-52. 10.1016/j.cca.2010.09.012, 20850423.
29. Salgado-Somoza A, Teijeira-Ferna´ndez E, Rubio J, Couso E, Gonza´lez-Juanatey JR, Eiras S. Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue. Clin Endocrinol (Oxf) 2012, 76:51-58. 10.1111/j.1365-2265.2011.04140.x.
30. Solini A, Stea F, Santini E, Bruno RM, Duranti E, Taddei S, Ghiadoni L. Adipocytokine levels mark endothelial function in normotensive individuals. Cardiovasc Diabetol 2012, 11:103. 10.1186/1475-2840-11-103, 22938533.
31. Farjo KM, Farjo RA, Halsey S, Moiseyev G, Ma JX. Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism. Mol Cell Biol 2012, 32:5103-5115. 10.1128/MCB.00820-12, 23071093.
32. Al-Daghri NM, Al-Attas OS, Alokail M, Draz HM, Bamakhramah A, Sabico S. Retinol binding protein-4 is associated with TNF-alpha and not insulin resistance in subjects with type 2 diabetes mellitus and coronary heart disease. Dis Markers 2009, 26:135-140. 10.1155/2009/725948, 19597296.
33. Staels B. Regulation of lipid and lipoprotein metabolism by retinoids. J Am Acad Dermatol 2001, 45:158-167. 10.1067/mjd.2001.113718.
34. von Eynatten M, Lepper PM, Liu D, Lang K, Baumann M, Nawroth PP, Bierhaus A, Dugi KA, Heemann U, Allolio B, Humpert PM. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 2007, 50:1930-1937. 10.1007/s00125-007-0743-8.
35. Verge`s B, Guiu B, Cercueil JP, Duvillard L, Robin I, Buffier P, Bouillet B, Aho S, Brindisi MC, Petit JM. Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 2012, 32:3050-3057. 10.1161/ATVBAHA.112.255190, 23087360.
36. Alwaili K1, Bailey D, Awan Z, Bailey SD, Ruel I, Hafiane A, Krimbou L, Laboissiere S, Genest J. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile. Biochim Biophys Acta 2012, 1821(3):405-415. 10.1016/j.bbalip.2011.07.013, 21840418.
37. Kaess BM, Enserro DM, McManus DD, Xanthakis V, Chen MH, Sullivan LM, Ingram C, O'Donnell CJ, Keaney JF, Vasan RS, Glazer NL. Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study. J Clin Endocrinol Metab 2012, 97:1943-1947. 10.1210/jc.2012-1458.
38. Frey SK1, Spranger J, Henze A, Pfeiffer AF, Schweigert FJ, Raila J. Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus. Metabolism 2009, 58(10):1386-1392. 10.1016/j.metabol.2009.05.003, 19501859.